Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model
- PMID: 12735719
- DOI: 10.14411/fp.2003.003
Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model
Abstract
Cryptosporidium parvum, Tyzzer, 1912 is identified as a common cause of diarrhoea in immunocompetent individuals. In immunocompromised, especially HIV-infected subjects, cryptosporidiosis causes severe chronic diarrhoea. In this study, nitazoxanide (NTZ) was compared for curative activity with sinefungin (SNF) and paromomycin (PRM) in immunosuppressed rats, a screening model for anticryptosporidial agents. NTZ at either 50 mg/kg/day, 100 mg/kg/day or 200 mg/kg/day resulted in seven days in a dose-dependent inhibition of oocyst shedding similar to that obtained with SNF (10 mg/kg/day) and PRM (100 mg/kg/day). Further discontinuation of SNF or PRM 100 mg/kg/day therapy resulted in early relapse of oocyst shedding which reached the pre-treatment levels in 2-4 days. In contrast, seven days after discontinuation of therapy, shedding inhibition was unchanged in NTZ-treated rats. Data prompt further assessment of the activity of NTZ on sequestered C. parvum.
Similar articles
-
Immunochemotherapy for cryptosporidiosis in immunosuppressed mouse model.J Egypt Soc Parasitol. 2007 Dec;37(3):945-56. J Egypt Soc Parasitol. 2007. PMID: 18383794
-
Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.Antimicrob Agents Chemother. 1998 Aug;42(8):1959-65. doi: 10.1128/AAC.42.8.1959. Antimicrob Agents Chemother. 1998. PMID: 9687390 Free PMC article.
-
The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001327. Epub 2021 Feb 23. J Med Microbiol. 2021. PMID: 33625354
-
Novel treatment strategies and drugs in development for cryptosporidiosis.Expert Rev Anti Infect Ther. 2018 Aug;16(8):655-661. doi: 10.1080/14787210.2018.1500457. Epub 2018 Jul 17. Expert Rev Anti Infect Ther. 2018. PMID: 30003818 Review.
-
Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?Parasitology. 2011 Oct;138(12):1488-91. doi: 10.1017/S0031182011000035. Epub 2011 Feb 15. Parasitology. 2011. PMID: 21320387 Review.
Cited by
-
Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.Vet Parasitol. 2009 Mar 9;160(1-2):149-54. doi: 10.1016/j.vetpar.2008.10.094. Epub 2008 Nov 5. Vet Parasitol. 2009. PMID: 19062195 Free PMC article. Clinical Trial.
-
Green Synthesis of Chitosan/Silver Nanoparticles Using Citrus paradisi Extract and Its Potential Anti-Cryptosporidiosis Effect.Pharmaceutics. 2024 Jul 22;16(7):968. doi: 10.3390/pharmaceutics16070968. Pharmaceutics. 2024. PMID: 39065665 Free PMC article.
-
Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.Parasitol Res. 2007 Dec;102(1):163-6. doi: 10.1007/s00436-007-0744-z. Epub 2007 Sep 15. Parasitol Res. 2007. PMID: 17874133 Clinical Trial.
-
In silico and in vivo evaluation of the anti-cryptosporidial activity of eugenol.Front Vet Sci. 2024 Mar 7;11:1374116. doi: 10.3389/fvets.2024.1374116. eCollection 2024. Front Vet Sci. 2024. PMID: 38515537 Free PMC article.
-
Polyphenolic Profile of Herniaria hemistemon Aerial Parts Extract and Assessment of Its Anti-Cryptosporidiosis in a Murine Model: In Silico Supported In Vivo Study.Pharmaceutics. 2023 Jan 26;15(2):415. doi: 10.3390/pharmaceutics15020415. Pharmaceutics. 2023. PMID: 36839737 Free PMC article.